Today: 12 May 2026
Browse Category

NASDAQ:ZBRA 12 May 2026

Stock Market Today

  • QuantumScape Shares Rise 11.7% on Eagle Line Launch and Initial Billings
    May 12, 2026, 5:46 PM EDT. QuantumScape (QS) gained 11.7% following the launch of its Eagle Line pilot-scale solid-state battery cell facility and initial $11 million in customer billings from ecosystem partners. The company reported a narrower GAAP net loss in Q1 2026, driven by reduced operating expenses. This marks a shift toward early commercialization and a potential licensing and royalty revenue stream, altering QuantumScape's risk profile and business model. Investors remain cautious as success depends on partner uptake and scaling production. Analysts' revenue forecasts vary widely, reflecting uncertainty around the new manufacturing blueprint. QuantumScape projects $544.5 million revenue and $33.3 million earnings by 2029, but some estimates are much lower, highlighting diverging market views.

Latest article

British American Tobacco Stock Jumps as FDA Shift Gives Vuse and Velo a Cleaner Read

British American Tobacco Stock Jumps as FDA Shift Gives Vuse and Velo a Cleaner Read

12 May 2026
British American Tobacco shares jumped 5.82% in London to £46.34 after the FDA signaled a softer enforcement stance on some e-cigarette and nicotine pouch products. A U.S. judge also dismissed BAT’s North Korea sanctions case following a $630 million settlement. The FTSE 100 slipped 0.04%. BAT’s U.S.-listed ADR closed up 5.3% at $63.64.
Camtek Stock Falls 16% After Earnings Beat as Margin Pressure and Hot CPI Hit AI Chip Trade

Camtek Stock Falls 16% After Earnings Beat as Margin Pressure and Hot CPI Hit AI Chip Trade

12 May 2026
Camtek shares fell 15.8% to $174.63 despite beating Q1 revenue and adjusted EPS estimates by small margins. Q1 revenue rose 2.5% year over year, but non-GAAP EPS dropped to $0.70 from $0.79 and operating margin narrowed to 25.5%. Management guided Q2 revenue to $129–$131 million and expects second-half revenue to rise over 25%. Broader market pressure followed a hot April CPI and rising Treasury yields.
Oscar Health stock rises in premarket after 2026 revenue outlook; House subpoenas add a fresh risk

Oscar Health Stock Extends Post-Earnings Repricing as Margins Outweigh ACA Risk

12 May 2026
Oscar Health shares rose 7.9% to $23.73 late Tuesday, with volume near 13 million, after posting strong Q1 profit and lower claims costs despite missing revenue estimates. The company’s medical loss ratio fell to 70.5% from 75.4% a year earlier. Membership climbed to 3.17 million. ACA enrollment churn and policy risk remain concerns.
Go toTop